Suppression of 6-pyruvoyl-tetrahydropterin synthase promotes remyelination in multiple sclerosis
Our findings suggest that PTS is a negative regulator of OPC proliferation, and its disinhibition could offer a potential therapeutic target for MS.
Authors
- Ying Long (ORCID: https://orcid.org/0009-0000-3634-6765)
- Yanqing Yin
- Ellen Ji (ORCID: https://orcid.org/0000-0003-1527-8868)
- Hui Xiao (ORCID: https://orcid.org/0000-0001-6283-6514)
- Gang Hu (ORCID: https://orcid.org/0000-0002-2864-4372)
- Yue Wu (ORCID: https://orcid.org/0000-0003-1449-5684)
- Yong-shun Guo (ORCID: https://orcid.org/0000-0002-0761-8538)
- Jiawei Zhou (ORCID: https://orcid.org/0000-0002-1844-9178)
- Yanyan Zhu (ORCID: https://orcid.org/0000-0001-6005-8421)
- Jun Gao (ORCID: https://orcid.org/0000-0002-5925-537X)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Chinese Academy of Sciences (CN)
- Nantong University (CN)
- Center for Excellence in Brain Science and Intelligence Technology (CN)
- University of Chinese Academy of Sciences (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1186/s12916-025-04351-0
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00